| Literature DB >> 27684594 |
Myka R Ababon1, Bo I Li2, Paul G Matteson1, James H Millonig3.
Abstract
Retinoic acid (RA) is an important developmental morphogen that coordinates anteroposterior and dorsoventral axis patterning, somitic differentiation, neurogenesis, patterning of the hindbrain and spinal cord, and the development of multiple organ systems. Due to its chemical nature as a small amphipathic lipid, direct detection and visualization of RA histologically remains technically impossible. Currently, methods used to infer the presence and localization of RA make use of reporter systems that detect the biological activity of RA. Most established reporter systems, both transgenic mice and cell lines, make use of the highly potent RA response element (RARE) upstream of the RAR-beta gene to drive RA-inducible expression of reporter genes, such as beta-galactosidase or luciferase. The transgenic RARE-LacZ mouse is useful in visualizing spatiotemporal changes in RA signaling especially during embryonic development. However, it does not directly measure overall RA levels. As a reporter system, the F9 RARE-LacZ cell line can be used in a variety of ways, from simple detection of RA to quantitative measurements of RA levels in tissue explants. Here we describe the quantitative determination of relative RA levels generated in embryos and neurosphere cultures using the F9 RARE-LacZ reporter cell line.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27684594 PMCID: PMC5091987 DOI: 10.3791/54443
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355
|
|
|
|
| 10% Sodium deoxycholate monohydrate (C24H39NaO4 · H2O) | 10 ml in 100 ml dH2O | 4 ºC |
| 1 M magnesium chloride (MgCl2) | RT | |
| 100x potassium ferrocyanide (K4[Fe(CN)6]·3H6O) | 2.12 g in 10 ml dH2O | RT in the dark |
| 100x potassium ferricyanide (K3[Fe(CN)6]) | 1.64 g in 10 ml dH2O | RT in the dark |
| 20 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside) | add 5 ml dimethyl formamide to make 20 mg/ml stock solution | -20 ºC |
| 10 mM (3 mg/ml) all-trans retinoic acid | Dissolve 50 mg in 16.67 ml absolute ethanol. Prepare 1 ml aliquots. | -80 ºC in the dark, in 1.5 ml amber microcentrifuge tubes |
| Papain | dissolve one vial in 7 ml HBSS | 4 ºC |
|
|
|
|
| F9 RARE-LacZ cell culture medium | 50 ml fetal bovine serum (FBS) (final concentration 10%) | Filter-sterilize. |
| 5 ml 100x Penicillin Streptomycin (final conc 1X) | Store at 4 ºC. | |
| 4 ml 50 mg/ml G418 (final conc 0.4 mg/ml) | ||
| to 500 ml DMEM/F-12 (with L-glutamine and HEPES) | ||
| 0.2% gelatin | 25 ml 2.0% gelatin | Store at 4 ºC. |
| 80 ml distilled water | ||
| Mix well | ||
| 70% ethanol | 30 ml 95% ethanol | Place in spray bottle. |
| 70 ml distilled water | Store at RT | |
| Neurosphere dissociation medium | 1 ml 20U papain | prepare fresh every time |
| 100 μl 13 mg/ml trypsin | ||
| 100 μl 7 mg/ml hyaluronic acid | ||
| 28 μl 10 mg/ml DNaseI | ||
| 50 μl 4mg/ml kynurenic acid | ||
| Neurosphere culture medium | DMEM/F-12 (with L-glutamine and HEPES) | prepare fresh every time |
| 2% B-27 supplement | ||
| 20 ng/ml fibroblast growth factor (FGF) | ||
| 20ng epidermal growth factor (EGF) | ||
| 2.5% glutaraldehyde | 250 μl 50% glutaraldehyde | prepare fresh every time |
| 4750 μl 1x PBS | ||
| LacZ wash solution | 0.5 ml 10% deoxycholate (final conc 0.1%) | Store at 4 ºC. |
| 1.0 ml 100% NP-40 (final conc 0.2%) | ||
| 50 ml 10X PBS | ||
| distilled water to 500 ml | ||
| X-gal staining solution | 1x potassium ferrocyanide | prepare fresh every time |
| 1x potassium ferricyanide | ||
| 1 mg/ml X-gal | ||
| to appropriate volume using LacZ wash solution | ||
| F9 RARE-LacZ freezing medium | F9 RARE-LacZ culture medium + 5% DMSO | prepare fresh every time |